Japan: the world's No 2 clinical diagnostics market
This article was originally published in Clinica
Executive Summary
The clinical diagnostics market in Japan has begun to exhibit moderate growth after an extended period of stagnation linked to the dormant Japanese economy. The volume of clinical diagnostic tests performed in Japan declined at single-digit rates in the early 2000s, including decreases in sales of immunodiagnostic tests. Growth in the Japanese clinical diagnostics market is still projected to be slow relative to the overall global market but, based on recent sales figures from Japanese suppliers, has recovered substantially and will approach the rate forecast for the US over the 2010-2015 period. In spite of its slow growth, Japan is the second-largest country market worldwide for clinical diagnostics products after the US, and accounts for over 10% of the global market.